HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target
Satellos Bioscience Inc
Satellos Bioscience Inc MSLE | 0.00 |
HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:
MSLE) with a Buy and maintains $11 price target.
